Načítá se...
Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events
The vascular endothelial growth factor (VEGF) signaling pathway (VSP) fulfills a cardinal role in endothelial cells and its inhibition has profound cardiovascular impact. This is true not only for the normal vasculature but also for the tumor vasculature when VSP inhibitors are used as anti-angiogen...
Uloženo v:
| Vydáno v: | J Am Soc Hypertens |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6168784/ https://ncbi.nlm.nih.gov/pubmed/29703600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jash.2018.03.008 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|